Lead sponsor
Zealand Pharma
11 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 6, 2026.
11
Trials led
2
Ongoing
1,187
Total enrollment
78
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Early Phase 1
2
Phase 1
7
Phase 2
2
Trials by status
Recruiting
1
Active, not recruiting
1
Completed
8
Terminated
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)BMI ≥27Ph 2Active, not recruiting221
A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570BMI 27-39.9Ph 1Terminated84
A Research Study Looking at the Safety of Multiple Doses of ZP8396 and How it Works in the Body of Healthy ParticipantsBMI 21-29.9Ph 1Completed68
A First-in-human Study Looking at the Safety of ZP8396 and How it Works in the Body of Healthy Trial ParticipantsBMI 21-29.9Ph 1Completed64
A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570BMI 18.5-28Early Ph 1Completed64
Investigating the Pharmacokinetics of Petrelintide Using Different Drug Product ConcentrationsBMI ≥27Ph 1Completed48
A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570BMI 18.5-28Early Ph 1Completed40
Pharmacokinetics of Petrelintide Following Administration to Participants With Impaired Renal FunctionBMI 21-40Ph 1Completed39
Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic FunctionBMI 18.5-40Ph 1Recruiting36